Literature DB >> 20585803

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): case report with a new mutation.

Zeren Bariş1, Tuba Eminoğlu, Buket Dalgiç, Leyla Tümer, Alev Hasanoğlu.   

Abstract

INTRODUCTION: Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare autosomal recessive multisystem disorder characterized by severe gastrointestinal dysmotility and leads to cachexia, ptosis, external ophthalmoplegia, peripheral neuropathy, and leukoencephalopathy. RESULTS AND DISCUSSION: It is often misdiagnosed as anorexia nervosa or intestinal pseudoobstuctions and are unnecessarily treated with surgery. It has been established that MNGIE is caused by mutations in the gene encoding thymidine phosphorylase, which lead to absolute or nearly complete loss of its catalytic activity, producing systemic accumulations of its substrates, thymidine and deoxyuridine.
CONCLUSION: We present herein the clinical, neuroimaging, and molecular findings of a patient with MNGIE caused by a novel homozygous TYMP gene mutation (c.112G>T which convert codon 38 from glutamate to a stop codon [p.38E>X]).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20585803     DOI: 10.1007/s00431-010-1237-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  8 in total

1.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) in two Mexican brothers harboring a novel mutation in the ECGF1 gene.

Authors:  Nancy Monroy; Luis R Macías Kauffer; Osvaldo M Mutchinick
Journal:  Eur J Med Genet       Date:  2008-01-09       Impact factor: 2.708

2.  Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.

Authors:  J Halter; Wmm Schüpbach; A Gratwohl; M Hirano; C Casali; R Elhasid; K Fay; S Hammans; I Illa; L Kappeler; S Krähenbühl; T Lehmann; H Mandel; R Marti; H Mattle; K Orchard; D Savage; C M Sue; D Valcarcel
Journal:  Bone Marrow Transplant       Date:  2010-05-03       Impact factor: 5.483

3.  Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).

Authors:  Jan-Willem Taanman; Mariza Daras; Juliane Albrecht; Charles A Davie; Elizabeth A Mallam; John R Muddle; Mark Weatherall; Thomas T Warner; Anthony H V Schapira; Lionel Ginsberg
Journal:  Neuromuscul Disord       Date:  2008-12-03       Impact factor: 4.296

Review 4.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes.

Authors:  Michio Hirano; Yutaka Nishigaki; Ramon Martí
Journal:  Neurologist       Date:  2004-01       Impact factor: 1.398

5.  Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency.

Authors:  Yutaka Nishigaki; Ramon Martí; William C Copeland; Michio Hirano
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

6.  Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder.

Authors:  I Nishino; A Spinazzola; M Hirano
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

7.  A novel TYMP mutation in a French Canadian patient with mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Robert Laforce; Paul N Valdmanis; Nicolas Dupré; Guy A Rouleau; Alexis F Turgeon; Martin Savard
Journal:  Clin Neurol Neurosurg       Date:  2009-06-12       Impact factor: 1.876

Review 8.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches.

Authors:  M C Lara; M L Valentino; J Torres-Torronteras; M Hirano; R Martí
Journal:  Biosci Rep       Date:  2007-06       Impact factor: 3.840

  8 in total
  10 in total

Review 1.  CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Authors:  Michio Hirano; Caterina Garone; Catarina M Quinzii
Journal:  Biochim Biophys Acta       Date:  2012-01-18

2.  Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Massimiliano Filosto; Mauro Scarpelli; Paola Tonin; Silvia Testi; Maria Sofia Cotelli; Mara Rossi; Andrea Salvi; Alberto Grottolo; Valentina Vielmi; Alice Todeschini; Gian Maria Fabrizi; Alessandro Padovani; Giuliano Tomelleri
Journal:  J Inherit Metab Dis       Date:  2011-04-19       Impact factor: 4.982

3.  Characteristics of intestinal pseudo-obstruction in patients with mitochondrial diseases.

Authors:  Yusuke Sekino; Masahiko Inamori; Eiji Yamada; Hidenori Ohkubo; Eiji Sakai; Takuma Higurashi; Hiroshi Iida; Kunihiro Hosono; Hiroki Endo; Takashi Nonaka; Hirokazu Takahashi; Tomoko Koide; Yasunobu Abe; Eiji Gotoh; Shigeru Koyano; Yoshiyuki Kuroiwa; Shin Maeda; Atsushi Nakajima
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

4.  Clinical and molecular characterization of a patient with mitochondrial Neurogastrointestinal Encephalomyopathy.

Authors:  Parham Habibzadeh; Mohammad Silawi; Hassan Dastsooz; Shima Bahramjahan; Shahrokh Ezzatzadegan Jahromi; Vahid Reza Ostovan; Majid Yavarian; Mohammad Mofatteh; Mohammad Ali Faghihi
Journal:  BMC Gastroenterol       Date:  2020-05-08       Impact factor: 3.067

Review 5.  Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far.

Authors:  Dario Pacitti; Michelle Levene; Caterina Garone; Niranjanan Nirmalananthan; Bridget E Bax
Journal:  Front Genet       Date:  2018-12-21       Impact factor: 4.599

6.  Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes.

Authors:  Jérémie Gautheron; Lara Lima; Baris Akinci; Jamila Zammouri; Martine Auclair; Sema Kalkan Ucar; Samim Ozen; Canan Altay; Bridget E Bax; Ivan Nemazanyy; Véronique Lenoir; Carina Prip-Buus; Cécile Acquaviva-Bourdain; Olivier Lascols; Bruno Fève; Corinne Vigouroux; Esther Noel; Isabelle Jéru
Journal:  BMC Med       Date:  2022-03-28       Impact factor: 8.775

7.  Clinical spectrum of early onset "Mediterranean" (homozygous p.P131L mutation) mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Sema Kalkan Uçar; Havva Yazıcı; Ebru Canda; Esra Er; Fatma Derya Bulut; Cenk Eraslan; Hüseyin Onay; Bridget Elizabeth Bax; Mahmut Çoker
Journal:  JIMD Rep       Date:  2022-07-10

8.  Mitochondrial neurogastrointestinal encephalomyopathy in a Pakistani female: a case report.

Authors:  Zaraq Rashid Khan; Alvina Karam; Mian Ayaz Ul Haq; Aleena Aman; Ahmad Sharjeel Karam
Journal:  J Med Case Rep       Date:  2022-10-03

Review 9.  Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE-MTDPS1).

Authors:  Massimiliano Filosto; Stefano Cotti Piccinelli; Filomena Caria; Serena Gallo Cassarino; Enrico Baldelli; Anna Galvagni; Irene Volonghi; Mauro Scarpelli; Alessandro Padovani
Journal:  J Clin Med       Date:  2018-10-26       Impact factor: 4.241

10.  Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment.

Authors:  Bridget E Bax
Journal:  J Transl Genet Genom       Date:  2020-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.